Page last updated: 2024-12-07
Molybdenum Mo-99
Molybdenum-99 (Mo-99) is a radioactive isotope of molybdenum. It is a key component in the production of technetium-99m (Tc-99m), a widely used medical radioisotope for diagnostic imaging. Mo-99 is produced by bombarding uranium-235 with neutrons in a nuclear reactor. The resulting fission products include Mo-99, which is then extracted and purified. Mo-99 decays by beta emission, with a half-life of 66 hours, into Tc-99m. Tc-99m is then used to create radiopharmaceuticals for a wide range of medical imaging applications, such as bone scans, heart scans, and lung scans. The importance of Mo-99 stems from its role in producing Tc-99m, which is essential for modern medical diagnostics. Its study is driven by the need to ensure a reliable and sustainable supply of Tc-99m for medical use. Research focuses on improving the production and separation of Mo-99, developing alternative methods for producing Tc-99m, and exploring new applications for Mo-99 itself. '
Cross-References
Synonyms (22)
Synonym |
14119-15-4 |
molybdenum mo-99 |
CHEBI:135936 |
molybdenum, isotope of mass 99 |
molybdenum-99 |
mo-99 |
unii-6634o61goi |
99mo radioisotope |
mo-99 radioisotope |
technelite |
99mo |
6634o61goi , |
molybdenum,mo-99 |
molybdenum (99-mo) |
mo 99 |
99 molybdenum |
molybdenum, mo-99 |
molybdenum,mo-99 [vandf] |
DTXSID70931019 |
(~99~mo)molybdenum |
Q2341055 |
molybdenum99 |
Drug Classes (1)
Class | Description |
transition element molecular entity | A molecular entity containing one or more atoms of a transition element. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 6 (54.55) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 46.25
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 46.25 (24.57) | Research Supply Index | 2.48 (2.92) | Research Growth Index | 4.76 (4.65) | Search Engine Demand Index | 89.36 (26.88) | Search Engine Supply Index | 2.70 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (9.09%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (90.91%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |